Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy-Reference-Cited by-同舟云学术

Tracking HCV protease population diversity during transmission and susceptibility of founder populations to antiviral therapy

Published:2017-03 Issue: Volume:139 Page:129-137
ISSN:0166-3542
Container-title:Antiviral Research
language:en
Short-container-title:Antiviral Research

Author:

Khera Tanvi,Todt Daniel,Vercauteren Koen,McClure C. Patrick,Verhoye Lieven,Farhoudi Ali,Bhuju Sabin,Geffers Robert,Baumert Thomas F.,Steinmann Eike,Meuleman Philip,Pietschmann Thomas,Brown Richard J.P.

Funder

European Union

NIH

LabEx HEPSYS

Ghent University

Innovation by Science and Technology

Belgian Science Policy Office

Publisher

Elsevier BV

Subject

Virology,Pharmacology

Reference33 articles.

1. Hepatitis C virus envelope glycoprotein fitness defines virus population composition following transmission to a new host;Brown;J. Virol.,2012

2. Analysis of serine codon conservation reveals diverse phenotypic constraints on hepatitis C virus glycoprotein evolution;Brown;J. Virol.,2014

3. Animal models for the study of hepatitis C virus infection and related liver disease;Bukh;Gastroenterology,2012

4. Grazoprevir, Elbasvir, and Ribavirin for chronic hepatitis C virus genotype 1 infection after failure of pegylated interferon and Ribavirin with an Earlier-generation protease inhibitor: final 24-week results from C-SALVAGE;Buti;Clin. Infect. Dis.,2016

5. WebLogo: a sequence logo generator;Crooks;Genome Res.,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Low Pathogenicity H7N3 Avian Influenza Viruses Have Higher Within-Host Genetic Diversity Than a Closely Related High Pathogenicity H7N3 Virus in Infected Turkeys and Chickens;Viruses;2022-03-08

2. Risk of rapid evolutionary escape from biomedical interventions targeting SARS-CoV-2 spike protein;PLOS ONE;2021-04-28

3. Risk of evolutionary escape from neutralizing antibodies targeting SARS-CoV-2 spike protein;2020-11-20

4. In vivo combination of human anti-envelope glycoprotein E2 and -Claudin-1 monoclonal antibodies for prevention of hepatitis C virus infection;Antiviral Research;2019-02

5. Animal Models to Study Hepatitis C Virus Infection;Frontiers in Immunology;2018-05-14